Cargando…
Inhibition of Angiotensin II-Induced Cardiac Hypertrophy and Associated Ventricular Arrhythmias by a p21 Activated Kinase 1 Bioactive Peptide
Cardiac hypertrophy increases the risk of morbidity and mortality of cardiovascular disease and thus inhibiting such hypertrophy is beneficial. In the present study, we explored the effect of a bioactive peptide (PAP) on angiotensin II (Ang II)-induced hypertrophy and associated ventricular arrhythm...
Autores principales: | Wang, Rui, Wang, Yanwen, Lin, Wee K., Zhang, Yanmin, Liu, Wei, Huang, Kai, Terrar, Derek A., Solaro, R. John, Wang, Xin, Ke, Yunbo, Lei, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094434/ https://www.ncbi.nlm.nih.gov/pubmed/25014109 http://dx.doi.org/10.1371/journal.pone.0101974 |
Ejemplares similares
-
Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy
por: Salama, Guy
Publicado: (2022) -
Use of a decoy peptide to purify p21 activated kinase-1 in cardiac muscle and identification of ceramide-related activation
por: Ke, Yunbo, et al.
Publicado: (2008) -
Unique catalytic activities and scaffolding of p21 activated kinase-1 in cardiovascular signaling
por: Ke, Yunbo, et al.
Publicado: (2013) -
Timing mechanisms to control heart rhythm and initiate arrhythmias: roles for intracellular organelles, signalling pathways and subsarcolemmal Ca(2+)
por: Terrar, Derek A.
Publicado: (2023) -
Novel bradykinin signaling in adult rat cardiac myocytes through activation of p21-activated kinase
por: Ke, Yunbo, et al.
Publicado: (2010)